(Reuters) - Pfizer Inc reported a 26 percent rise in quarterly profit on Tuesday, driven by higher sales of its drugs, including breast cancer treatment Ibrance.
The U.S. drugmaker said net income rose to $3.87 billion, or 65 cents per share, in the second quarter, from $3.07 billion, or 51 cents per share, a year earlier.
Revenue rose 4.4 percent to $13.47 billion.
(Reporting by Tamara Mathias in Bengaluru; Editing by Sriraj Kalluvila)
Disclaimer: No Business Standard Journalist was involved in creation of this content